LeukoScan(R). For use in diagnostic imaging of the long bones and feet in patients with suspected osteomyelitis, including those with diabetic foot ulcers
Medical Services Advisory Committee
Record ID 32003001185
English
Authors' objectives:
This review aims to assess the effectiveness and cost-effectiveness of LeukoScan(R), a radiopharmaceutical used in the detection of osteomyelitis.
Authors' recommendations:
LeukoScan(R) is safe and as effective as current methods of WBC scanning, but is more costly. MSAC recommends that additional funding is justified for patients who do not have access to ex-vivo scanning.
Authors' methods:
Systematic review
Details
Project Status:
Completed
URL for project:
http://www.msac.gov.au/
Year Published:
2003
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Australia
MeSH Terms
- Costs and Cost Analysis
- Leukocyte Count
- Leukocytes
- Osteomyelitis
- Leukocyte Disorders
Contact
Organisation Name:
Medical Services Advisory Committee
Contact Address:
MSAC (MDP 107), GPO Box 9848, Canberra, ACT 2601, Australia. Tel: +61 2 6289 6811; Fax: +61 2 6289 8799.
Contact Name:
msac.secretariat@health.gov.au
Contact Email:
msac.secretariat@health.gov.au
Copyright:
Medicare Services Advisory Committee (MSAC)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.